Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bone marrow stem cell niche is a highly specialized and dynamic microenvironment within the bone marrow that maintains and regulates hematopoietic stem cells (HSCs)[1][9]. It consists of a network of different cell types, including mesenchymal stem/stromal cells (MSCs), endothelial cells, osteoblasts, adipocytes, pericytes, Schwann cells, as well as hematopoietic and immune lineage cells such as osteoclasts, macrophages, and regulatory T cells[2][3][7][8]. The niche provides biochemical and physical cues necessary for the self-renewal, quiescence, differentiation, migration, and survival of HSCs[1][2][4][5][9]. Disruption or remodeling of the niche is implicated in various diseases, especially hematologic malignancies (e.g., leukemia), bone marrow failure syndromes, and is affected during both aging and stress[2][7][9]. While the niche itself is not a direct molecular therapeutic target, components of the niche (e.g., signaling pathways involving CXCL12, SCF, and adhesion molecules) are being investigated as potential drug targets for modulating hematopoiesis and treating marrow-related diseases[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone marrow stem cell niche.